Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miconazole vs Miconazole-Loaded Chitosan Nanoparticles for Oral Candidiasis in Diabetics
NCT06072716Phase 1Completed
- Start
- Jan 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of miconazole in oral candidiasis (2 arms). Primary endpoint: Clinical assessment of erythematous/psuedomembranous oral candidiasis resolution at 28 days. Started Jan 2023; status: completed.
02
Drugs
miconazole
03
Conditions
oral candidiasis
Beyond the preview
Go deeper on NCT06072716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06072716.